Skip to main content

Table 1 Patients characteristics stratified by PD-L1 expression levels

From: Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer

Variables

All cases

(N = 4550)

PD-L1 TPS

P values

PD-L1 < 1%

(N = 3017)

1 ≤ PD-L1 ≤ 49%

(N = 1013)

PD-L1 ≥ 50%

(N = 520)

Age (years)

    

P < 0.001

 Median (IQR)

62 (55, 68)

62 (54, 67)

62 (55, 68)

64 (58, 69)

 

Mean (SD)

61.1 (9.4)

60.7 (9.6)

61.2 (9.3)

62.9 (8.5)

 

 Range

(17, 85)

(17, 85)

(20, 84)

(34, 83)

 

Sex

    

P < 0.001

 Female

2204

1679 (76.2)

404 (18.3)

121 (5.5)

 

 Male

2346

51

1338 (57.0)

609 (26.0)

399 (17.0)

 

Smoking history

    

P < 0.001

 Yes

1815

975 (53.7)

499 (27.5)

341 (18.8)

 

 No

2735

2042 (74.7)

514 (18.8)

179 (6.5)

 

Histology

    

P < 0.001

 AIS/MIA

156

151 (96.8)

5 (3.2)

0 (0)

 

 IAC

3660

2619 (71.6)

744 (20.3)

297 (8.1)

 

 SQCC

642

213 (33.2)

229 (35.7)

200 (31.2)

 

 LCC

49

27 (55.1)

13 (26.5)

9 (18.4)

 

 ASC

25

1 (4.0)

15 (60.0)

9 (36.0)

 

 Others

18

6 (33.3)

7 (38.9)

5 (27.8)

 

T stage

    

P < 0.001

 T0/1

3022

2262 (74.9)

555 (18.4)

205 (6.8)

 

 T2

936

443 (47.3)

303 (32.4)

190 (20.3)

 

 T3

303

155 (51.2)

79 (26.1)

69 (22.8)

 

 T4

224

126 (56.3)

62 (27.7)

36 (16.1)

 

 Tx

65

31 (47.7)

14 (21.5)

20 (30.8)

 

N stage

    

P < 0.001

 N0

3502

2558 (73.0)

657 (18.8)

287 (8.2)

 

 N1

323

140 (43.3)

113 (35.0)

70 (21.7)

 

 N2

679

298 (43.9)

230 (33.9)

151 (22.2)

 

 N3

40

19 (47.5)

10 (25.0)

11 (27.5)

 

 Nx

6

2 (33.3)

3 (50.0)

1 (16.7)

 

M stage

    

P < 0.001

 M0

4353

2915 (67.0)

966 (22.2)

472 (10.8)

 

 M1

56

39 (69.6)

9 (16.1)

8 (14.3)

 

 Mx

141

63 (44.7)

38 (27.0)

40 (28.4)

 

TNM stage

    

P < 0.001

 0/IA

2633

2082 (79.1)

423 (16.1)

128 (4.9)

 

 IB

422

229 (54.3)

121 (28.7)

72 (17.1)

 

 II

524

247 (47.1)

163 (31.1)

114 (21.8)

 

 III

773

356 (46.1)

259 (33.5)

158 (20.4)

 

 IV

56

39 (69.6)

9 (16.1)

8 (14.3)

 

 x

142

64 (45.1)

38 (26.8)

40 (28.2)

 

STAS

    

P < 0.001

 Absence

1927

1555 (80.7)

295 (15.3)

77 (4.0)

 

 Presence

981

555 (56.6)

301 (30.7)

125 (12.7)

 

 Unknown

1642

907 (55.2)

417 (25.4)

318 (19.4)

 
  1. TPS: tumor proportion score; IQR: interquartile range; SD: standard deviation; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IAC: invasive adenocarcinoma; SQCC: squamous cell carcinoma; LCC: large cell carcinoma; ASC: adenosquamous carcinoma; STAS: spread through air spaces